Genomic and Phenotypic Evaluation of the Gliadin-Degrading Probiotic Bacillus amyloliquefaciens EG025 from Cheonggukjang for Celiac Disease Treatment.

Probiotics Antimicrob Proteins · 2026 · PMC13176060 · PMID 40892163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

amyloliquefaciens EG025 demonstrated a survival rate of 81.7% after 2 h of incubation, and despite a decreasing trend over time, maintained a relatively high survival rate of 62.5% even after 6 h.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.